{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:44:23Z","timestamp":1794469463004,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitamin E supplementation might have favorable effects on risk factors of polycystic ovary syndrome (PCOS). This systematic review and meta-analysis aimed to summarize the effects of vitamin E supplementation or vitamin E in combination with omega-3 or magnesium on PCOS. PubMed, Scopus, ISI Web of Science, Cochrane, Embase electronic databases, and Google scholar were searched for all available articles up to September 2022. Randomized controlled trials (RCTs) that examined the effect of vitamin E supplementation or vitamin E in combination with omega-3 or magnesium on lipid and glycemic profiles, anthropometric measurements, biomarkers of inflammation and oxidative stress, hormonal profile, and hirsutism score in patients with PCOS were included. Ten RCTs (with 504 participants) fulfilled the eligible criteria. Vitamin E supplementation or vitamin E in combination with omega-3 or magnesium in comparison to placebo could significantly reduce serum levels of TG (weighted mean difference: \u2212\u00a018.27\u00a0mg\/dL, 95% CI \u2212\u00a034.68 to \u2212\u00a01.87), VLDL (\u2212\u00a05.88\u00a0mg\/dL, 95% CI \u2212\u00a08.08 to \u2212\u00a03.68), LDL-c (\u2212\u00a012.84\u00a0mg\/dL, 95% CI \u2212\u00a022.15 to \u2212\u00a03.52), TC (\u2212\u00a016.30\u00a0mg\/dL, 95% CI \u2212\u00a029.74 to \u2212\u00a02.86), TC\/HDL-c ratio (\u2212\u00a00.52, 95% CI \u2212\u00a00.87 to \u2212\u00a00.18), hs-CRP (\u2212\u00a00.60\u00a0ng\/mL, 95% CI \u2212\u00a00.77 to \u2212\u00a00.44), hirsutism score (\u2212\u00a00.33, 95% CI \u2212\u00a00.65 to \u2212\u00a00.02) and significantly increase nitric oxide levels (2.79\u00a0\u00b5mol\/L, 95% CI 0.79\u20134.79). No significant effect was found on HDL-c, glycemic indices, hormonal profile, anthropometric measurements, and other biomarkers of inflammation or oxidative stress. This meta-analysis highlights the potential anti-hyperlipidemic, anti-oxidant, and anti-inflammatory properties of vitamin E supplementation alone or in combination with omega-3 or magnesium on PCOS patients.<\/jats:p>","DOI":"10.1038\/s41598-022-24467-0","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:02:27Z","timestamp":1668855747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome"],"prefix":"10.1038","volume":"12","author":[{"given":"Hajar","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hajhashemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvane","family":"Saneei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"2","key":"24467_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.dsx.2016.06.025","volume":"11","author":"A Sadeghi","year":"2017","unstructured":"Sadeghi, A., Djafarian, K., Mohammadi, H. & Shab-Bidar, S. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. Diabetes Metab Syndr. 11(2), 157\u2013162 (2017) (Epub 2016\/08\/04).","journal-title":"Diabetes Metab Syndr."},{"issue":"1","key":"24467_CR2","first-page":"44","volume":"15","author":"S Shirazi","year":"2021","unstructured":"Shirazi, S., Gargari, B. P., Izadi, A., Taghizadeh, S. & Parizad, M. Effect of vitamin E on serum levels of vascular endothelial growth factor and angiopoietin-1 in women with polycystic ovary syndrome: A pilot randomized, placebo-controlled trial. Int. J. Fert. Steril. 15(1), 44 (2021).","journal-title":"Int. J. Fert. Steril."},{"issue":"10","key":"24467_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.amjmed.2014.04.017","volume":"127","author":"TL Setji","year":"2014","unstructured":"Setji, T. L. & Brown, A. J. Polycystic ovary syndrome: update on diagnosis and treatment. Am. J. Med. 127(10), 912\u2013919 (2014).","journal-title":"Am. J. Med."},{"issue":"4","key":"24467_CR4","first-page":"352","volume":"18","author":"S Mohammadi","year":"2017","unstructured":"Mohammadi, S., Kayedpoor, P., Karimzadeh-Bardei, L. & Nabiuni, M. The effect of curcumin on TNF-\u03b1, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state. J. Reprod. Infert. 18(4), 352 (2017).","journal-title":"J. Reprod. Infert."},{"issue":"2","key":"24467_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1210\/jc.2007-1756","volume":"93","author":"O Valkenburg","year":"2008","unstructured":"Valkenburg, O. et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study. J. Clin. Endocrinol. Metab. 93(2), 470\u2013476 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"24467_CR6","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild, R. A. et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95(5), 2038\u20132049 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24467_CR7","doi-asserted-by":"crossref","unstructured":"Tal, R., Seifer, D. B., Arici, A., editors. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. Seminars in reproductive medicine. Thieme Medical Publishers (2015).","DOI":"10.1055\/s-0035-1552582"},{"issue":"7","key":"24467_CR8","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1210\/en.2012-1105","volume":"153","author":"D Abramovich","year":"2012","unstructured":"Abramovich, D. et al. Angiopoietins\/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology 153(7), 3446\u20133456 (2012).","journal-title":"Endocrinology"},{"key":"24467_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112741","volume":"254","author":"F Heydarpour","year":"2020","unstructured":"Heydarpour, F. et al. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis. J. Ethnopharmacol. 254, 112741 (2020) (Epub 2020\/03\/11).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"24467_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12958-018-0346-x","volume":"16","author":"K Yang","year":"2018","unstructured":"Yang, K., Zeng, L., Bao, T. & Ge, J. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: A systematic review and meta-analysis. Reprod. Biol. Endocrinol. 16(1), 27 (2018) (Epub 2018\/03\/28).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"6","key":"24467_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","volume":"77","author":"F Ovalle","year":"2002","unstructured":"Ovalle, F. & Azziz, R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil. Steril. 77(6), 1095\u20131105 (2002).","journal-title":"Fertil. Steril."},{"issue":"3","key":"24467_CR12","first-page":"238","volume":"62","author":"F Mehrabian","year":"2011","unstructured":"Mehrabian, F., Khani, B., Kelishadi, R. & Ghanbari, E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol. Pol. 62(3), 238\u2013242 (2011).","journal-title":"Endokrynol. Pol."},{"key":"24467_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fphar.2017.00444","volume":"8","author":"SK Wong","year":"2017","unstructured":"Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Ahmad, F. & Ima-Nirwana, S. Vitamin E as a potential interventional treatment for metabolic syndrome: evidence from animal and human studies. Front. Pharmacol. 8, 444 (2017).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"24467_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12011-018-1602-9","volume":"191","author":"M Shokrpour","year":"2019","unstructured":"Shokrpour, M. & Asemi, Z. The effects of magnesium and vitamin E co-supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. Biol. Trace Elem. Res. 191(1), 54\u201360 (2019).","journal-title":"Biol. Trace Elem. Res."},{"issue":"06","key":"24467_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0042-117773","volume":"125","author":"FA Ebrahimi","year":"2017","unstructured":"Ebrahimi, F. A. et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Exp. Clin. Endocrinol. Diabetes 125(06), 353\u2013359 (2017).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"24467_CR16","first-page":"319","volume":"104","author":"A Izadi","year":"2019","unstructured":"Izadi, A. et al. Hormonal and metabolic effects of coenzyme Q10 and\/or vitamin E in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 104(2), 319\u2013327 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"02","key":"24467_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/a-0749-6431","volume":"51","author":"M Jamilian","year":"2019","unstructured":"Jamilian, M., Sabzevar, N. K. & Asemi, Z. The effect of magnesium and vitamin E co-supplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Horm. Metab. Res. 51(02), 100\u2013105 (2019).","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"24467_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2019.04.004","volume":"50","author":"A Izadi","year":"2019","unstructured":"Izadi, A., Shirazi, S., Taghizadeh, S. & Gargari, B. P. Independent and additive effects of coenzyme Q10 and vitamin E on cardiometabolic outcomes and visceral adiposity in women with polycystic ovary syndrome. Arch. Med. Res. 50(2), 1\u201310 (2019).","journal-title":"Arch. Med. Res."},{"key":"24467_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-020-00930-w","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: A retrospective cohort study. BMC Womens Health 20, 1\u20139 (2020).","journal-title":"BMC Womens Health"},{"issue":"6","key":"24467_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5001\/omj.2018.88","volume":"33","author":"HR Talari","year":"2018","unstructured":"Talari, H. R. et al. The effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome. Oman Med. J. 33(6), 473 (2018).","journal-title":"Oman Med. J."},{"key":"24467_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14302\/issn.2379-7835.ijn-19-3006","volume":"1","author":"F Sadeghi","year":"2019","unstructured":"Sadeghi, F., Alavi-Naeini, A., Mardanian, F., Ghazvini, M. R. & Mahaki, B. Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese\/overweight women with polycystic ovary syndrome. Int. J. Vit. Nutr. Res. 1, 1 (2019).","journal-title":"Int. J. Vit. Nutr. Res."},{"key":"24467_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jad.2017.12.049","volume":"229","author":"M Jamilian","year":"2018","unstructured":"Jamilian, M. et al. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J. Affect. Disord. 229, 41\u201347 (2018).","journal-title":"J. Affect. Disord."},{"key":"24467_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mce.2016.09.008","volume":"439","author":"E Rahmani","year":"2017","unstructured":"Rahmani, E. et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein (a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol. Cell. Endocrinol. 439, 247\u2013255 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"key":"24467_CR24","unstructured":"Eldridge, S., Campbell, M., Campbell, M., Drahota-Towns, A., Giraudeau, B., Higgins, J., et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2.0): additional considerations for cluster-randomized trials (2016)."},{"key":"24467_CR25","doi-asserted-by":"crossref","unstructured":"Higgins, J. P., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J. et al. Cochrane handbook for systematic reviews of interventions: John Wiley & Sons (2019).","DOI":"10.1002\/9781119536604"},{"issue":"4","key":"24467_CR26","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.dsx.2019.07.001","volume":"13","author":"O Asbaghi","year":"2019","unstructured":"Asbaghi, O., Choghakhori, R. & Abbasnezhad, A. Effect of Omega-3 and vitamin E co-supplementation on serum lipids concentrations in overweight patients with metabolic disorders: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab. Syndr. 13(4), 2525\u20132531 (2019) (Epub 2019\/08\/14).","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"24467_CR27","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.dsx.2019.03.018","volume":"13","author":"M Sepidarkish","year":"2019","unstructured":"Sepidarkish, M. et al. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on lipid profile: A systematic review and meta-analysis. Diabetes Metab. Syndr. 13(2), 1649\u20131656 (2019) (Epub 2019\/07\/25).","journal-title":"Diabetes Metab. Syndr."},{"key":"24467_CR28","doi-asserted-by":"publisher","first-page":"102450","DOI":"10.1016\/j.ctim.2020.102450","volume":"52","author":"S Zuo","year":"2020","unstructured":"Zuo, S. et al. The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials. Complement Ther. Med. 52, 102450 (2020).","journal-title":"Complement Ther. Med."},{"issue":"18","key":"24467_CR29","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.lfs.2005.12.001","volume":"78","author":"CK Sen","year":"2006","unstructured":"Sen, C. K., Khanna, S. & Roy, S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 78(18), 2088\u20132098 (2006).","journal-title":"Life Sci."},{"issue":"5\u20136","key":"24467_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1024\/0300-9831\/a000599","volume":"90","author":"SP Moosavian","year":"2020","unstructured":"Moosavian, S. P., Arab, A., Mehrabani, S., Moradi, S. & Nasirian, M. The effect of omega-3 and vitamin E on oxidative stress and inflammation: Systematic review and meta-analysis of randomized controlled trials. Int. J. Vitam. Nutr. Res. 90(5\u20136), 553\u2013563 (2020) (Epub 2019\/08\/24).","journal-title":"Int. J. Vitam. Nutr. Res."},{"issue":"2","key":"24467_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jgh.15221","volume":"36","author":"A Vadarlis","year":"2021","unstructured":"Vadarlis, A. et al. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 36(2), 311\u2013319 (2021) (Epub 2020\/08\/19).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"24467_CR32","doi-asserted-by":"publisher","first-page":"e95008","DOI":"10.1371\/journal.pone.0095008","volume":"9","author":"R Xu","year":"2014","unstructured":"Xu, R., Zhang, S., Tao, A., Chen, G. & Zhang, M. Influence of vitamin E supplementation on glycaemic control: A meta-analysis of randomised controlled trials. PLoS ONE 9(4), e95008 (2014).","journal-title":"PLoS ONE"},{"issue":"6","key":"24467_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","volume":"15","author":"JN Sharma","year":"2007","unstructured":"Sharma, J. N., Al-Omran, A. & Parvathy, S. S. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15(6), 252\u2013259 (2007) (Epub 2008\/02\/01).","journal-title":"Inflammopharmacology"},{"key":"24467_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","volume":"63","author":"DS Bredt","year":"1994","unstructured":"Bredt, D. S. & Snyder, S. H. Nitric oxide: A physiologic messenger molecule. Annu. Rev. Biochem. 63, 175\u2013195 (1994) (Epub 1994\/01\/01).","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"24467_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/sj.bjp.0706855","volume":"149","author":"M Marshall","year":"2006","unstructured":"Marshall, M., Keeble, J. & Moore, P. K. Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia. Br. J. Pharmacol. 149(5), 516\u2013522 (2006) (Epub 2006\/08\/31).","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"24467_CR36","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1177\/0300060519864493","volume":"47","author":"C Meng","year":"2019","unstructured":"Meng, C. Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): A meta-analysis. J. Int. Med. Res. 47(9), 4083\u20134094 (2019) (Epub 2019\/08\/23).","journal-title":"J. Int. Med. Res."},{"key":"24467_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2014.03.035","volume":"72","author":"Q Jiang","year":"2014","unstructured":"Jiang, Q. Natural forms of vitamin E: Metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radical. Biol. Med. 72, 76\u201390 (2014).","journal-title":"Free Radical. Biol. Med."},{"issue":"5","key":"24467_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/molecules24050923","volume":"24","author":"K-L Pang","year":"2019","unstructured":"Pang, K.-L. & Chin, K.-Y. The role of tocotrienol in protecting against metabolic diseases. Molecules 24(5), 923 (2019).","journal-title":"Molecules"},{"issue":"2","key":"24467_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/cr.2010.13","volume":"20","author":"Y-X Wang","year":"2010","unstructured":"Wang, Y.-X. PPARs: Diverse regulators in energy metabolism and metabolic diseases. Cell. Res. 20(2), 124\u2013137 (2010).","journal-title":"Cell. Res."},{"issue":"21","key":"24467_CR40","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.2174\/138161211796957472","volume":"17","author":"J Bardhan","year":"2011","unstructured":"Bardhan, J., Chakraborty, R. & Raychaudhuri, U. The 21st century form of vitamin E-Tocotrienol. Curr. Pharm. Des. 17(21), 2196\u20132205 (2011).","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"24467_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.mad.2010.03.005","volume":"131","author":"R Pazdro","year":"2010","unstructured":"Pazdro, R. & Burgess, J. R. The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 131(4), 276\u2013286 (2010).","journal-title":"Mech. Ageing Dev."},{"issue":"1\u20133","key":"24467_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejphar.2007.12.011","volume":"582","author":"L Jin","year":"2008","unstructured":"Jin, L., Xue, H.-Y., Jin, L.-J., Li, S.-Y. & Xu, Y.-P. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 582(1\u20133), 162\u2013167 (2008).","journal-title":"Eur. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24467-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T21:31:26Z","timestamp":1668893486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24467-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24467-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19927"}}